SELP and colorectal cancer: Because P-selectin-mediated platelet accumulation accelerates insulinoma growth, we recombined mP-sel-Fc and hP-sel-Fc [22] to treat the 5-weeks-old or 9 weeks-old Rip1-Tag2 mice for three weeks and xenografted human colorectal cancers.